Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:Healthcare PM Team Writes New Prescription for Forward Not Rated 0.0 Email Routing List Email & Route  Print Print
Tuesday, October 16, 2012

Healthcare PM Team Writes New Prescription for Forward

Reported by Tommy Fernandez

San Francisco fund manager Forward Management [profile] has hired a global healthcare investment team away from Asymmetry Capital Management.

The team includes portfolio manager Scott Kay, who was a founding partner at Asymmetry Capital Management as well as, previously, a founding partner at Partner Fund Management, where he served as therapeutic sector head. Before that, he had been a senior healthcare analyst at Andor Capital Management, and at Bank America Securities. Earlier in his career he held various roles in marketing, sales and operations at Pfizer Inc. .

Kay brings two senior analysts, who previously worked with him, to Forward.

Also joining the team is Chris Zellner, who will be responsible for operations and business development.   He brings to the team two decades of global markets and investment banking experience with Bank of America Merrill Lynch, Lehman Brothers and Morgan Stanley, among others.




Company Press Release

Forward Adds Dedicated Healthcare Investment Team



San Francisco, Oct. 16, 2012 -- Forward (Forward Management, LLC) has announced the addition of the Asymmetry global healthcare team. The firm plans to offer a long/short equity strategy investing globally across all healthcare sectors and market capitalizations, in early 2013.

"This new team adds an important and exciting dimension to Forward's investment capabilities. Much like the technology sector, healthcare is a fast-growing, rapidly changing industry that is experiencing a variety of disruptions. For managers who understand the industry's dynamics, this translates into a multitude of long and short investment opportunities," said Alan Reid, CEO of Forward.  

Scott Kay is the portfolio manager for the team. A 20-year healthcare industry veteran, Scott was a founding partner at Partner Fund Management, LP, where he was therapeutic sector head. Previously he was a senior healthcare analyst at Andor Capital Management, LLC and at Bank America Securities, where he was ranked among top healthcare analysts by Institutional Investor. Earlier in his career he held various roles in marketing, sales and operations at Pfizer.

Also joining the team is Chris Zellner, who will be responsible for operations and business development.   He brings to the team two decades of global markets and investment banking experience with Bank of America Merrill Lynch, Lehman Brothers and Morgan Stanley, among others. Two senior analysts, both of whom have previously worked with Scott, will round out the team.   

About Forward

?The world has changed, leading investors to seek new strategies that better fit an evolving global climate. Forward's investment solutions are built around the outcomes we believe investors need to be pursuing - non-correlated return, investment income, global exposure and diversification. With a propensity for unbounded thinking, we focus especially on developing innovative alternative strategies that may help investors build all-weather portfolios. An independent, privately held firm founded in 1998, Forward (Forward Management, LLC) is the advisor to the Forward Funds. As of September 30, 2012, we manage $5.7 billion in a diverse product set offered to individual investors, financial advisors and institutions. More information on Forward can be found at www.forwardinvesting.com.  

Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

0.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2025: Q1
2024: Q4Q3Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly


  1. MMI webinar - Enhancing the Advisor Experience, January 16
  2. MFDF webinar - AI and Fund Compliance, January 21
  3. MFDF In Focus - In Focus: Small Boards' Use of Skills Matrices, January 22
  4. IDC webinar - SEC Enforcement Trends: What Fund Directors Should Know, January 23
  5. ICI webinar - Legal and Compliance Career Opportunities in the Asset Management Industry, January 24
  6. FSI OneVoice 2025, Jan 27-29
  7. MFDF 2025 Directors' Institute, Jan 27-29
  8. Nicsa webinar - An Intro to Irish and Luxembourg Investment Platforms for US Asset Managers, January 29
  9. WE South - Dallas | Texas Stock Exchange, Politics, & Product Development, January 30
  10. 2025 ICI Innovate, Feb 3-5
  11. Nicsa webinar - AI In Operations: Boosting Productivity for Wealth & Asset Management Firms, February 5
  12. MFDF In Focus: Understanding Distribution - What the Data Can Tell You, February 6
  13. MFDF Director Discussion Series - Open Forum, February 10
  14. MFDF Director Discussion Series - Open Forum, February 11
  15. MMI Darden-in-Residence II, Feb 24-6
  16. 2025 MMI RIA Forum, February 27
  17. IDC Core Responsibilities of Fund Directors, February 27
  18. Citywire Scottsdale CIO Summit 2025, Feb 27-28
  19. Expect Miracles In Manhattan 2025, February 27
  20. T3 Technology Conference 2025, Mar 3-6
  21. IMEA Distribution Intelligence Summit, Mar 4-5
  22. Nicsa 2025 Strategic Leadership Forum, Mar 5-7
  23. Citywire Pro Buyer New York Due Diligence Retreat 2025, Mar 6-7
  24. MFDF 2025 Fund Governance & Regulatory Insights Conference, Mar 6-7
  25. MFDF 15(c) White Paper Webinar Series: Part 3 - Gartenberg Factors Analysis and Challenges, March 12
  26. ICI Investment Management Conference, Mar 16-19




©All rights reserved to InvestmentWires, Inc. 1997-2025
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use